ANI Pharmaceuticals Q4 2022 Earnings Preview

Mar. 08, 2023 1:03 PM ETANI Pharmaceuticals, Inc. (ANIP)By: Anuron Mitra, SA News Editor
  • ANI Pharmaceuticals (NASDAQ:ANIP) is scheduled to announce Q4 earnings results on Thursday, March 9th, before market open.
  • The consensus EPS Estimate is $0.67 (+24.1% Y/Y) and the consensus Revenue Estimate is $86.14M (+41.4% Y/Y).
  • Over the last 2 years, ANIP has beaten EPS estimates 50% of the time and has beaten revenue estimates 88% of the time.
  • Over the last 3 months, EPS estimates have seen 1 upward revision and 1 downward. Revenue estimates have seen 2 upward revisions and 0 downward.

Recommended For You

Comments

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.